![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Center for Serotonin Disorders Research and Department of Pharmacology (Y.Z., T.S.G., D.N.D., G.A.C., K.J.D., B.D., F.G., G.M.Z., N.R.S.H., G.B., N.A.M., L.D.V.d.K.) and Department of Cell Biology, Neurology, and Anatomy (T.S.G.), Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois
An imbalance between serotonin-2A (5-HT2A) and 5-HT1A receptors may underlie several mood disorders. The present studies determined whether 5-HT2A receptors interact with 5-HT1A receptors in the rat hypothalamic paraventricular nucleus (PVN). The sensitivity of the hypothalamic 5-HT1A receptors was measured as oxytocin and adrenocorticotropic hormone (ACTH) responses to the 5-HT1A receptor agonist (+)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide [(+)8-OH-DPAT] (40 µg/kg s.c.). The 5-HT2A/2C receptor agonist (-)DOI [(-)-1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane HCl] (1 mg/kg s.c.) injected 2 h prior to (+)8-OH-DPAT significantly reduced the oxytocin and ACTH responses to (+)8-OH-DPAT, producing a heterologous desensitization of the 5-HT1A receptors. Microinjection of the 5-HT2A receptor antagonist MDL100,907 [(+)-
-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol; 0, 10, or 20 nmol, 15 min prior to (-)DOI] into the PVN dose-dependently prevented the desensitization of 5-HT1A receptors induced by the 5-HT2A receptor agonist (-)DOI. Double-label immunocytochemistry revealed a high degree of colocalization of 5-HT1A and 5-HT2A receptors in the oxytocin and corticotropin-releasing factor neurons of the PVN. Thus, activation of 5-HT2A receptors in the PVN may directly induce a heterologous desensitization of 5-HT1A receptors within individual neuroendocrine cells. These findings may provide insight into the long-term adaptation of 5-HT1A receptor signaling after changes in function of 5-HT2A receptors; for example, during pharmacotherapy of mood disorders.
Address correspondence to: Dr. Louis D. Van de Kar, Department of Pharmacology, Loyola University of Chicago, Stritch School of Medicine, 2160 South First Avenue, Maywood, Illinois 60153. E-mail: lvandek{at}lumc.edu
This article has been cited by other articles:
![]() |
L. K. Heisler, N. Pronchuk, K. Nonogaki, L. Zhou, J. Raber, L. Tung, G. S. H. Yeo, S. O'Rahilly, W. F. Colmers, J. K. Elmquist, et al. Serotonin Activates the Hypothalamic-Pituitary-Adrenal Axis via Serotonin 2C Receptor Stimulation J. Neurosci., June 27, 2007; 27(26): 6956 - 6964. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Carrasco, L. D. Van de Kar, C. Jia, H. Xu, Z. Chen, R. Chadda, F. Garcia, N. A. Muma, and G. Battaglia Single Exposure to a Serotonin 1A Receptor Agonist, (+)8-Hydroxy-2-(di-n-propylamino)-tetralin, Produces a Prolonged Heterologous Desensitization of Serotonin 2A Receptors in Neuroendocrine Neurons in Vivo J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1078 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Osei-Owusu, A. James, J. Crane, and K. E. Scrogin 5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1324 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, A. Holmes, L. Ma, L. D. Van de Kar, F. Garcia, and D. L. Murphy Medial Hypothalamic 5-Hydroxytryptamine (5-HT)1A Receptors Regulate Neuroendocrine Responses to Stress and Exploratory Locomotor Activity: Application of Recombinant Adenovirus Containing 5-HT1A Sequences J. Neurosci., December 1, 2004; 24(48): 10868 - 10877. [Abstract] [Full Text] [PDF] |
||||